MARIANA TUDORAN, CRISTINA TUDORAN, TUDOR CIOCARLIE, GHEORGHE NICUSOR POP,MARCEL MIHAI BERCEANU-VADUVA, DANA EMILIA VELIMIROVICI*, ABU AWWAD AHMED, DELIA MIRA BERCEANU-VADUVA ASPECTS OF HEART FAILURE IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER PERCUTANEOUS CORONARY REVASCULARIZATION WITH POLYMER-COATED DRUG-ELUTING STENTS VERSUS BARE-METAL STENTS Percutaneous coronary revascularization (PCR) with polymer-coated drug-eluting stents (DES) or bare-metal stents (BMS) is considered the standard therapy in advanced ischemic heart disease (IHD). Despite revascularisation, many of these patients subsequently develop heart failure with reduced ejection fraction (HFrEF). We analysed 51 patients with IHD, treated by PCR and insertion of DES and/or BMS who later developed HFrEF. Patients with DES where more likely women, of younger age and a higher incidence of diabetes mellitus compared to patients with BMS who were generally men, of older age and had more frequently acute ST-elevation myocardial infarction (STEMI) as indication for PCR. Although patients with DES had more severe IHD, their EF was higher, possibly due to the benefits offered by the DES.